Amyotrophic Lateral Sclerosis Report
: Analysis on the Market, Trends, and TechnologiesThe business domain of amyotrophic lateral sclerosis (ALS) encompasses a multifaceted ecosystem involving R&D, healthcare, biotechnology, and pharmaceuticals sectors. The data reflects a robust engagement of 847 companies, indicating a substantial scope for growth and innovation in addressing this serious neurological disorder. With a notable $15.52 billion in funding, the industry demonstrates a stable foundation for advancements and research, despite fluctuations in growth and media coverage. The surge in interest and investment in related medical disciplines underscores a growing focus on improving treatment options and patient care for neurological disorders.
This report was last updated 110 days ago. Spot an error or missing detail? Help us fix it by getting in touch!
Topic Dominance Index of Amyotrophic Lateral Sclerosis
To identify the Dominance Index of Amyotrophic Lateral Sclerosis in the Trend and Technology ecosystem, we look at 3 different time series: the timeline of published articles, founded companies, and global search. These timelines are normalized and combined to show a comprehensive view of the Amyotrophic Lateral Sclerosis evolution relative to all known Trends and Technologies.
Key Activities and Applications
- Clinical stage development of biologic treatments for neurological diseases and wound healing.
- Health information provision, including community forums and support groups.
- Drug development targeting brain and nervous system diseases with a focus on zinc and nerve cell regeneration.
- Therapeutic and prophylactic treatments for neurological diseases like Parkinson's and multiple sclerosis.
- Commercialization and development of diagnostics and therapeutics for growth hormone deficiency and other conditions.
- Pharmaceutical and chemical company innovation targeting improved patient health and quality of life.
- Support and management services for patients and families coping with illnesses and injuries.
- Collaborative community and assistive technology hub for people with disabilities.
- Development of nerve stem cell technology for spinal cord injury treatment.
- Sport science and performance tools integration for goal achievement.
Emergent Trends and Core Insights
- A trending focus on neurological disorders and therapeutic advancements.
- Increased investment in biotechnology and R&D within the ALS domain.
- A shift toward patient-centric services and personalized care models.
- Growth in the use of assistive technologies and community support systems.
- Expansion of funding and financial support from notable investors.
- Development of novel drugs and technologies targeting nerve cell protection and regeneration.
Technologies and Methodologies
- Biologic treatments leveraging genetically engineered proteins.
- Strategic research approaches in drug development.
- Innovative prophylactic and therapeutic treatments using stochastic resonance.
- First and only approved oral tests for adult growth hormone deficiency diagnosis.
- Next-generation software solutions for computer accessibility.
- Non-viral gene therapy platforms for immune modulation.
- Computational drug discovery and early-stage drug validation tools.
Amyotrophic Lateral Sclerosis Funding
A total of 226 Amyotrophic Lateral Sclerosis companies have received funding.
Overall, Amyotrophic Lateral Sclerosis companies have raised $15.9B.
Companies within the Amyotrophic Lateral Sclerosis domain have secured capital from 722 funding rounds.
The chart shows the funding trendline of Amyotrophic Lateral Sclerosis companies over the last 5 years
Amyotrophic Lateral Sclerosis Companies
The Companies feature is a crucial part of TrendFeedr. It offers in-depth information about 777 companies working within Amyotrophic Lateral Sclerosis and other trends and technologies. Identify and analyze innovators and key players in relevant industries more easily with this feature.
777 Amyotrophic Lateral Sclerosis Companies
Discover Amyotrophic Lateral Sclerosis Companies, their Funding, Manpower, Revenues, Stages, and much more
Amyotrophic Lateral Sclerosis Investors
TrendFeedr’s investors tool offers a detailed view of investment activities that align with specific trends and technologies. This tool features comprehensive data on 249 Amyotrophic Lateral Sclerosis investors, funding rounds, and investment trends, providing an overview of market dynamics.
249 Amyotrophic Lateral Sclerosis Investors
Discover Amyotrophic Lateral Sclerosis Investors, Funding Rounds, Invested Amounts, and Funding Growth
Amyotrophic Lateral Sclerosis News
Stay informed and ahead of the curve with TrendFeedr’s News feature, which provides access to 5.3K Amyotrophic Lateral Sclerosis articles. The tool is tailored for professionals seeking to understand the historical trajectory and current momentum of changing market trends.
5.3K Amyotrophic Lateral Sclerosis News Articles
Discover Latest Amyotrophic Lateral Sclerosis Articles, News Magnitude, Publication Propagation, Yearly Growth, and Strongest Publications
Executive Summary
The ALS business domain is characterized by dynamic growth and resilience, with companies engaging in groundbreaking research and patient-centered innovations. The industry's commitment to advancing medical care is evident through substantial investments and the development of novel treatments aimed at neurological disorders. As the sector continues to evolve, it maintains a strong focus on improving patient outcomes and exploring new frontiers in biotechnology and healthcare.
Interested in enhancing our coverage of trends and tech? We value insights from experts like you - reach out!
